Amit Kumar

About

Health care professional working on systems biology platforms to elucidate disease mechanism and finding biomarkers and drug targets.

Employment

• Merck & Co Inc Senior Scientist
  2017 - Present
• St Jude Children's Research Hospital Postdoctoral Research Associate
  2016 - 2017
• MedImmune LLC Intern
  2014 - 2015
• NIH Fellow
  2011 - 2015
• Biocon Limited Executive
  2008 - 2010

Education

• Johns Hopkins University PhD
  2010 - 2015
• Indian Institute of Technology Madras Bachelor of Technology
  2004 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• A proteomics approach to decipher a sticky CHO situation
  Biotechnology and Bioengineering 2022 DOI: 10.1002/bit.28108
  +Save
• Lessons from the Hamster: Cricetulus griseus Tissue and CHO Cell Line Proteome Comparison
  Journal of Proteome Research 2017 DOI: 10.1021/acs.jproteome.7b00382
  +Save
• High-Throughput Lipidomic and Transcriptomic Analysis To Compare SP2/0, CHO, and HEK-293 Mammalian Cell Lines
  Analytical Chemistry 2017 DOI: 10.1021/acs.analchem.6b02984
  +Save
• Cellular traffic cops: the interplay between lipids and proteins regulates vesicular formation, trafficking, and signaling in mammalian cells.
  Current opinion in biotechnology 2015 DOI: 10.1016/j.copbio.2015.09.006
  +Save
• Elucidation of the CHO Super-Ome (CHO-SO) by Proteoinformatics.
  Journal of proteome research 2015 DOI: 10.1021/acs.jproteome.5b00588
  +Save
• The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice.
  Nutrition & metabolism 2015 DOI: 10.1186/s12986-015-0003-8
  +Save
• Coupling enrichment methods with proteomics for understanding and treating disease.
  Proteomics. Clinical applications 2015 DOI: 10.1002/prca.201400097
  +Save
• Multi-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice.
  PloS one 2014 DOI: 10.1371/journal.pone.0102319
  +Save
• Exploiting the proteomics revolution in biotechnology: from disease and antibody targets to optimizing bioprocess development.
  Current opinion in biotechnology 2014 DOI: 10.1016/j.copbio.2014.06.006
  +Save
• Proteomic analysis of Chinese hamster ovary cells.
  Journal of proteome research 2012 DOI: 10.1021/pr300476w
  +Save